Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn C Hartmann

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Annals of Surgical Oncology|June 23, 2010
Pseudoangiomatous stromal hyperplasia and breast cancer riskAmy C Degnim, Marlene H Frost, Derek C Radisky, et al.
Cancer|October 15, 2008
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Breast Cancer Research and Treatment|September 24, 2009
Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasiaMarta Santisteban, Carol Reynolds, Emily G Barr Fritcher, et al.
Genes, Chromosomes & Cancer|July 6, 2004
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriersCamilo Adem, Cheryl L Soderberg, Kari Hafner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profilesFrank De Smet, Nathalie L M M Pochet, Bart L R De Moor, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2011
Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancerFritcher Emily G Barr, Amy C Degnim, Lynn C Hartmann, et al.
Gynecologic Oncology|May 8, 2009
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancerAbraham Peedicayil, Robert A Vierkant, Vijayalakshmi Shridhar, et al.
Breast Cancer Research and Treatment|August 13, 2015
Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort StudyAziza Nassar, Daniel W Visscher, Amy C Degnim, et al.
Cancer|June 29, 2016
Breast cancer risk by the extent and type of atypical hyperplasiaAmy C Degnim, Daniel W Visscher, Derek C Radisky, et al.
Gynecologic Oncology|April 26, 2011
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinomaS John Weroha, Ann L Oberg, Katie L Allen Ziegler, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Annals of Surgical Oncology|June 23, 2010
Pseudoangiomatous stromal hyperplasia and breast cancer riskAmy C Degnim, Marlene H Frost, Derek C Radisky, et al.
Cancer|October 15, 2008
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Breast Cancer Research and Treatment|September 24, 2009
Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasiaMarta Santisteban, Carol Reynolds, Emily G Barr Fritcher, et al.
Genes, Chromosomes & Cancer|July 6, 2004
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriersCamilo Adem, Cheryl L Soderberg, Kari Hafner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Independent test set performance in the prediction of early relapse in ovarian cancer with gene expression profilesFrank De Smet, Nathalie L M M Pochet, Bart L R De Moor, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2011
Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancerFritcher Emily G Barr, Amy C Degnim, Lynn C Hartmann, et al.
Gynecologic Oncology|May 8, 2009
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancerAbraham Peedicayil, Robert A Vierkant, Vijayalakshmi Shridhar, et al.
Breast Cancer Research and Treatment|August 13, 2015
Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort StudyAziza Nassar, Daniel W Visscher, Amy C Degnim, et al.
Cancer|June 29, 2016
Breast cancer risk by the extent and type of atypical hyperplasiaAmy C Degnim, Daniel W Visscher, Derek C Radisky, et al.
Gynecologic Oncology|April 26, 2011
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinomaS John Weroha, Ann L Oberg, Katie L Allen Ziegler, et al.
Pageof 15